A systematic review of health-related quality of life instruments in patients with cancer cachexia

Supportive Care in Cancer

Volumn 21, Issue 9, 2013, Pages 2625-2636

  Wheelwright, Sally ^a,d   Darlington, Anne Sophie ^a   Hopkinson, Jane B ^b   Fitzsimmons, Deborah ^c   White, Alice ^a   Johnson, Colin D ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cachexia; Cancer; Health related quality of life; Systematic review

Indexed keywords

CACHEXIA; CANCER PATIENT; EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE C30; FUNCTIONAL ASSESSMENT OF ANOREXIA CACHEXIA THERAPY; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

ANOREXIA; CACHEXIA; HEALTH STATUS; HUMANS; NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84881245813     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1881-9     Document Type: Review

References (105)

1. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495. doi: 10.1016/s1470-2045(10)70218-7
2. Bruera E (1997) ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 315(7117):1219-1222 (Pubitemid 27478219)
3. Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2(11):862-871. doi: 10.1038/nrc927nrc927 (Pubitemid 37328904)
4. Churm D, Andrew IM, Holden K, Hildreth AJ, Hawkins C (2009) A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 17(5):503-507. doi: 10.1007/s00520-008-0486-1
5. Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, Leslie WT (2000) Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 9(10):1137-1146 (Pubitemid 32452957)
6. Aaronson NK (1990) Quality of life research in cancer clinical trials: a need for common rules and language. Oncology (Williston Park) 4(5):59-66, discussion 70
7. Souter J (2005) Loss of appetite: a poetic exploration of cancer patients' and their carers' experiences. Int J Palliat Nurs 11(10):524-532
8. Muir CI, Linklater GT (2011) A qualitative analysis of the nutritional requirements of palliative care patients. J Hum Nutr Diet 24(5):470-478. doi: 10.1111/j.1365-277X.2011.01182.x
9. McClement SE, Degner LF, Harlos MS (2003) Family beliefs regarding the nutritional care of a terminally ill relative: a qualitative study. J Palliat Med 6(5):737-748. doi: 10.1089/109662103322515248 (Pubitemid 38435450)
10. Reid J, McKenna H, Fitzsimons D, McCance T (2009) The experience of cancer cachexia: a qualitative study of advanced cancer patients and their family members. Int J Nurs Stud 46(5):606-616. doi: 10.1016/j.ijnurstu.2008.10. 012
11. Hopkinson J, Corner J (2006) Helping patients with advanced cancer live with concerns about eating: a challenge for palliative care professionals. J Pain Symptom Manage 31(4):293-305. doi: 10.1016/j.jpainsymman.2005.09.005
12. Strasser F, Binswanger J, Cerny T, Kesselring A (2007) Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study. Palliat Med 21(2):129-137. doi: 10.1177/0269216307076346 (Pubitemid 46455839)
13. Orrevall Y, Tishelman C, Herrington MK, Permert J (2004) The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 23(6):1280-1287. doi: 10.1016/j.clnu.2004.04.006 (Pubitemid 39517621)
14. Hinsley R, Hughes R (2007) 'The reflections you get': an exploration of body image and cachexia. Int J Palliat Nurs 13(2):84-89
15. Holden CM (1991) Anorexia in the terminally ill cancer patient: the emotional impact on the patient and the family. Hosp J 7(3):73-84
16. Gwilliam B, Bailey C (2001) The nature of terminal malignant bowel obstruction and its impact on patients with advanced cancer. Int J Palliat Nurs 7(10):474-481
17. Locher JL, Robinson CO, Bailey FA, Carroll WR, Heimburger DC, Saif MW, Tajeu G, Ritchie CS (2010) Disruptions in the organization of meal preparation and consumption among older cancer patients and their family caregivers. Psychooncology 19(9):967-974. doi: 10.1002/pon.1656
18. Hopkinson J, Wright D, Corner J (2006) Exploring the experience of weight loss in people with advanced cancer. J Adv Nurs 54(3):304-312. doi: 10.1111/j.1365-2648.2006.03818 (Pubitemid 43611003)
19. Centre for Reviews and Dissemination (2009) Systematic reviews: CRD's guidance for undertaking reviews in health care [Internet]
20. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6(7):e1000097. doi: 10.1371/journal.pmed.1000097
21. Argiles JM, Anker SD, Evans WJ, Morley JE, Fearon KCH, Strasser F, Muscaritoli M, Baracos VE (2010) Consensus on cachexia definitions. J Am Med Dir Assoc 11(4):229-230. doi: 10.1016/j.jamda.2010.02.004
22. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC (2011) Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. doi:10.1007/s11136-011-9960-1
23. Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D'Haese S, Zurlo A (2003) Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials - does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 21(18):3502-3511. doi: 10.1200/JCO.2003.12.121JCO.2003.12. 121 (Pubitemid 46594084)
24. Cella DF, Bonomi AE, Leslie WT, VonRoenn J, Tchekmedyian NS (1993) Quality of life and nutritional well-being: measurement and relationship. Oncology 7(11):105-111
25. Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S, Sullivan M, Westin T (1998) Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck-J Sci Spec Head Neck 20(6):540-548 (Pubitemid 28361460)
26. Ollenschlager G, Thomas W, Konkol K, Diehl V, Roth E (1992) Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia. Eur J Clin Investig 22(8):546-553
27. Riechelmann RP, Burman D, Tannock IF, Rodin G, Zimmermann C (2010) Phase II Trial of Mirtazapine for Cancer-Related Cachexia and Anorexia. Am J Hosp Pallia Med 27(2):106-110. doi: 10.1177/1049909109345685
28. Mantovani G, Maccio A, Madeddu C, Gramignano G, Lusso MR, Serpe R, Massa E, Astara G, Deiana L (2006) A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomark Prev 15(5):1030-1034. doi: 10.1158/1055-9965.epi-05-0538 (Pubitemid 43823535)
29. Poole K, Froggatt K (2002) Weight loss in advanced cancer: a literature review. London
30. Gavazzi C, Colatruglio S, Sironi A, Mazzaferro V, Miceli R (2011) Importance of early nutritional screening in patients with gastric cancer. Br J Nutr 106(12):1773-1778
31. Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko YD, Schnelle M, Reif M, Cerny T (2006) Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia- Study-Group. J Clin Oncol 24(21):3394-3400. doi: 10.1200/jco.2005.05.1847 (Pubitemid 46638895)
32. Wiedenmann B, Malfertheiner P, Friess H, Ritch P, Arseneau J, Mantovani G, Caprioni F, Van Cutsem E, Richel D, DeWitte M, Qi M, Robinson D, Zhong B, De Boer C, Lu JD, Prabhakar U, Corringham R, Von Hoff D (2008) A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J Support Oncol 6(1):18-25 (Pubitemid 351227865)
33. Bowling A (2005) Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf) 27(3):281-291. doi: 10.1093/pubmed/fdi031 (Pubitemid 41298086)
34. Cocks K, King MT, Velikova G, Fayers PM, Brown JM (2008) Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. Eur J Cancer 44(13):1793-1798. doi: 10.1016/j.ejca.2008.05. 008
35. Fitzsimmons D, Wheelwright S, Johnson CD (2012) Quality of life in pulmonary surgery: choosing, using, and developing assessment tools. Thorac Surg Clin 22(4):457-470. doi: 10.1016/j.thorsurg.2012.07.007
36. Fayers P, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes, 2nd edn. John Wiley & Sons, Chichester
37. Guyatt G, Schunemann H (2007) How can quality of life researchers make their work more useful to health workers and their patients? Qual Life Res 16(7):1097-1105. doi: 10.1007/s11136-007-9223-3 (Pubitemid 47357724)
38. Evans WJ, Lambert CP (2007) Physiological basis of fatigue. Am J Phys Med Rehabil Assoc Acad Phys 86(1 Suppl):S29-46
39. Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83(6):1345-1350 (Pubitemid 44713065)
40. Ravasco P, Camilo M (2006) Patient-centered outcomes in cancer: nutrition makes a real difference. Curr Nutr Food Sci 2(2):193-203. doi: 10.2174/157340106776818871 (Pubitemid 44027824)
41. Persson CR, Johansson BBK, Sjoden PO, Glimelius BLG (2002) A randomized study of nutritional support in patients with colorectal and gastric cancer. Nutr Cancer Int J 42(1):48-58 (Pubitemid 35007006)
42. Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME (2004) Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12(4):246-252. doi: 10.1007/s00520-003-0568- (Pubitemid 38660747)
43. Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S (2010) Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 91(4):1133S-1137S. doi: 10.3945/ajcn.2010.28608C
44. Hopkinson JB (2010) The emotional aspects of cancer anorexia. Curr Opin Support Palliat Care 4(4):254-258. doi: 10.1097/SPC.0b013e32833ef813
45. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376 (Pubitemid 23073154)
46. The EuroQol Group (1990) EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 16(3):199-208
47. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570-579 (Pubitemid 23071057)
48. Berk L, James J, Schwartz A, Hug E, Mahadevan A, Samuels M, Kachnic L (2008) A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer 16(10):1179-1188. doi: 10.1007/s00520-008-0403-7
49. Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J, Summers N, Brown B, Dulude H, Gallant G (1998) Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Cancer Prev Control 2(2):74-78 (Pubitemid 28222429)
50. Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R (1997) Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy. Eur J Cancer 33(1):75-79 (Pubitemid 27099571)
51. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group Study. J Clin Oncol 20(2):567-573 (Pubitemid 34072541)
52. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B (2004) An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22(12):2469-2476. doi: 10.1200/jco.2004.06.024 (Pubitemid 41115406)
53. Kornek GV, Schenk T, Ludwig H, Hejna M, Scheithauer W (1996) Placebo-controlled trial of medroxyprogesterone acetate in gastrointestinal malignancies and cachexia. Onkologie 19(2):164-168
54. Lindholm E, Daneryd P, Korner U, Hyltander A, Fouladiun M, Lundholm K (2004) Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients. Clin Cancer Res 10(20):6855-6864 (Pubitemid 39383034)
55. Lundholm K, Korner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I (2007) Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13(9):2699-2706. doi: 10.1158/1078-0432.ccr-06-2720 (Pubitemid 46788038)
56. Lundholm K, Gunnebo L, Korner U, Iresjo BM, Engstrom C, Hyltander A, Smedh U, Bosaeus I (2010) Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients a randomized double-blind study. Cancer 116(8):2044-2052. doi: 10.1002/cncr.24917
57. McMillan DC, Wigmore SJ, Fearon KC, O'Gorman P, Wright CE, McArdle CS (1999) A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 79(3-4):495-500. doi: 10.1038/sj.bjc.6690077 (Pubitemid 29046225)
58. Navari RM, Brenner MC (2010) Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Support Care Cancer 18(8):951-956. doi: 10.1007/s00520-009-0739-7
59. Simons J, Aaronson NK, Vansteenkiste JF, tenVelde GPM, Muller MJ, Drenth BM, Erdkamp FLG, Cobben EGM, Schoon EJ, Smeets JBE, Schouten HC, Demedts M, Hillen HFP, Blijham GH, Wouters EFM (1996) Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. J Clin Oncol 14(4):1077-1084 (Pubitemid 26105512)
60. Tozer RG, Tai P, Falconer W, Ducruet T, Karabadjian A, Bounous G, Molson JH, Droge W (2008) Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy. Antioxid Redox Signal 10(2):395-402. doi: 10.1089/ars.2007.1919
61. Trabal J, Leyes P, Forga M, Maurel J (2010) Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 25(5):736-740. doi: 10.3305/nh.2010.25.5.4616
62. Vadell C, Segui MA, Gimenez-Arnau JM, Morales S, Cirera L, Bestit I, Batiste E, Blanco R, Jolis L, Boleda M, Anton I (1998) Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Am J Clin Oncol Cancer Clin Trials 21(4):347-351 (Pubitemid 28366901)
63. Westman G, Bergman B, Albertsson M, Kadar L, Gustavsson G, Thaning L, Andersson M, Straumits A, Jeppson B, Linden CJ, Ewers SB, Andersson H, Mercke C, Hafstrom L, Birck O, Orgum P (1999) Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial. Eur J Cancer 35(4):586-595 (Pubitemid 29192967)
64. Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL (2010) A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer 68(2):234-239
65. Persson C, Glimelius B (2002) The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy. Anticancer Res 22(6B):3661-3668 (Pubitemid 36132846)
66. Baldwin C, Spiro A, McGough C, Norman AR, Gillbanks A, Thomas K, Cunningham D, O'Brien M, Andreyev HJN (2011) Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet 24(5):431-440. doi: 10.1111/j.1365-277X.2011.01189.x
67. Breitkreutz R, Tesdal K, Jentschura D, Haas O, Leweling H, Holm E (2005) Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: a randomized controlled study. Wien Klin Wochenschr 117(19-20):685-692. doi: 10.1007/s00508-005-0455-3 (Pubitemid 41719684)
68. Davidson W, Ash S, Capra S, Bauer J (2004) Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 23(2):239-247. doi: 10.1016/j.clnu.2003.07.001 S026156140300133X (Pubitemid 38401219)
69. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10):1479-1486 (Pubitemid 37176729)
70. Hasenberg T, Essenbreis M, Herold A, Post S, Shang E (2010) Early supplementation of parenteral nutrition is capable of improving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectal carcinoma undergoing palliative treatment: Results from a prospective, randomized clinical trial. Color Dis 12(10):e190-e199. doi: 10.1111/j.1463-1318.2009.02111.x
71. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN (2002) Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 183(4):471-479 (Pubitemid 34442515)
72. Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP (1993) Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11(10):2043-2049 (Pubitemid 23304632)
73. Poon RT, Yu WC, Fan ST, Wong J (2004) Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther 19(7):779-788. doi: 10.1111/j.1365-2036.2004.01920.x (Pubitemid 38496644)
74. Shang E, Weiss C, Post S, Kaehler G (2006) The influence of early supplementation of parenteral nutrition on quality of life and body composition in patients with advanced cancer. J Parenter Enter Nutr 30(3):222-230
75. Van VB-d, der Schuer MA, Langendoen SI, Vondeling H, Kuik DJ, Quak JJ, Van Leeuwen PA (2000) Perioperative enteral nutrition and quality of life of severely malnourished head and neck cancer patients: a randomized clinical trial. Clin Nutr 19(6):437-444. doi: 10.1054/clnu.2000.0148
76. Taylor LA, Pletschen L, Arends J, Unger C, Massing U (2010) Marine phospholipids - a promising new dietary approach to tumor-associated weight loss. Support Care Cancer 18(2):159-170
77. Read JA, Beale PJ, Volker DH, Smith N, Childs A, Clarke SJ (2007) Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 15(3):301-307. doi: 10.1007/s00520-006-0153-3 (Pubitemid 46295216)
78. Burns CP, Halabi S, Clamon G, Kaplan E, Hohl RJ, Atkins JN, Schwartz MA, Wagner BA, Paskett E (2004) Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia - a cancer and leukemia group B study. Cancer 101(2):370-378. doi: 10.1002/cncr.20362 (Pubitemid 38890842)
79. Mantovani G, Madeddu C, Maccio A, Gramignano G, Lusso MR, Massa E, Astara G, Serpe R (2004) Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomark Prev 13(10):1651-1659 (Pubitemid 39331888)
80. Neri B, Gemelli MT, Tarantini P, Benvenuti F, Khader A, Ludovici M, Michelotti R, Fabbroni S (1995) The role of megestrol-acetate in neoplastic anorexia and cachexia. CurrTher Res Clin Exp 56(2):183-189
81. Skarlos DV, Fountzilas G, Pavlidis N, Beer M, Makrantonakis P, Aravantinos G, Pantelakos P, Tsavaris N, Karpasitis N, Kosmidis P (1993) Megestrol-acetate in cancer-patients with anorexia and weight-loss - a hellenic cooperative oncology group (HECOG) study. Acta Oncol 32(1):37-41 (Pubitemid 23080771)
82. Mantovani G, Maccio A, Madeddu C, Serpe R, Antoni G, Massa E, Dessi M, Panzone F (2010) Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. J Mol Med-Jmm 88(1):85-92. doi: 10.1007/s00109-009-0547-z
83. Chasen M, Hirschman SZ, Bhargava R (2011) Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia. J Am Med Dir Assoc 12(1):62-67. doi: 10.1016/j.jamda.2010.02. 012
84. Bozzetti F, Cozzaglio L, Biganzoli E, Chiavenna G, De Cicco M, Donati D, Gilli G, Percolla S, Pironi L (2002) Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 21(4):281-288. doi: 10.1054/clnu.2002.0560 (Pubitemid 34846882)
85. Bauer JD, Capra S (2005) Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy - a pilot study. Support Care Cancer 13(4):270-274. doi: 10.1007/s00520-004-0746-7 (Pubitemid 40576515)
86. Ferrucci LM, Bell D, Thornton J, Black G, McCorkle R, Heimburger DC, Saif MW (2011) Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer 19(11):1729-1734. doi: 10.1007/s00520-010-1011-x
87. Fouladiun M, Korner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I, Lundholm K (2007) Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res 13:6379-6385. doi: 10.1158/1078-0432.ccr-07-1147 (Pubitemid 350075027)
88. van den Berg MG, Rasmussen-Conrad EL, van Nispen L, van Binsbergen JJ, Merkx MA (2008) A prospective study on malnutrition and quality of life in patients with head and neck cancer. Oral Oncol 44(9):830-837. doi: 10.1016/j.oraloncology.2007.11.002
89. Dahele M, Skipworth RJ, Wall L, Voss A, Preston T, Fearon KC (2007) Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain Symptom Manage 33(6):676-685. doi: 10.1016/j.jpainsymman.2006.09.024 (Pubitemid 46783987)
90. Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34(4):503-509 (Pubitemid 28179346)
91. Norman K, Stobaus N, Smoliner C, Zocher D, Scheufele R, Valentini L, Lochs H, Pirlich M (2010) Determinants of hand grip strength, knee extension strength and functional status in cancer patients. Clin Nutr 29(5):586-591
92. Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156-165. doi: 10.1016/j.jpainsymman.2006.07.017 (Pubitemid 46186864)
93. Chang VT, Xia Q, Kasimis B (2005) The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients. J Support Oncol 3(5):377-382 (Pubitemid 41448264)
94. Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, Cannon T, Stewart PW, Weissler MC, Shores CG (2007) Defining cancer cachexia in head and neck squamous cell carcinoma. Clin Cancer Res 13(22 Pt 1):6561-6567. doi: 10.1158/1078-0432.ccr-07-0116 (Pubitemid 350206789)
95. Xara S, Amaral TF, Parente B (2011) Undernutrition and quality of life in non-small cell lung cancer patients. Revista Portuguesa De Pneumologia 17(4):153-158. doi: 10.1016/j.rppneu.2011.01.006
96. Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433-437. doi: 10.1007/s00520-009-0681-8
97. Shahmoradi N, Kandiah M, Peng LS (2009) Impact of nutritional status on the quality of life of advanced cancer patients in hospice home care. Asian Pacific J Cancer Prev 10(6):1003-1009
98. Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, Tankel K, Courneya KS, Reiman T (2008) Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer. J Thorac Oncol 3(2):194-195 (Pubitemid 351323198)
99. Nourissat A, Vasson MP, Merrouche Y, Bouteloup C, Goutte M, Mille D, Jacquin JP, Collard O, Michaud P, Chauvin F (2008) Relationship between nutritional status and quality of life in patients with cancer. Eur J Cancer 44(9):1238-1242. doi: 10.1016/j.ejca.2008.04.006
100. Correia M, Cravo M, Marques-Vidal P, Grimble R, Dias-Pereira A, Faias S, Nobre-Leitao C (2007) Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer. Clin Nutr 26(6):728-735. doi: 10.1016/j.clnu.2007.08.014 (Pubitemid 350082498)
101. O'Gorman P, McMillan DC, McArdle CS (1998) Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer Int J 32(2):76-80 (Pubitemid 29039504)
102. Ovesen L, Hannibal J, Mortensen EL (1993) The interrelationship of weight-loss, dietary-intake, and quality-of-life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer Int J 19(2):159-167 (Pubitemid 23131433)
103. Scott HR, McMillan DC, Brown DJ, Forrest LM, McArdle CS, Milroy R (2003) A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer 40(3):295-299 (Pubitemid 36627709)
104. Capuano G, Pavese I, Satta F, Tosti M, Palladino A, Del Grosso A, Di Palma M (2008) Correlation between anemia, unintentional weight loss and inflammatory status on cancer-related fatigue and quality of life before chemo and radiotherapy. e-SPEN 3(4):e147-e151. doi: 10.1016/j.eclnm.2008.04.008
105. Petruson KM, Silander EM, Hammerlid EB (2005) Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck-J Sci Specialt Head Neck 27(4):302-310. doi: 10.1002/hed.20172 (Pubitemid 40418602)